💥 ¡Por fin! Dosis adicionales de refuerzos bivalentes de COVID-19 disponibles en EE. UU. para *ciertos* grupos poblacionales
Posts en Español Vaccines
Aparna Kumar, PhD CRNP MPH
La FDA, por sus siglas en inglĂ©s, modificĂł la autorizaciĂłn de uso de emergencia en los Estados Unidos de las vacunas de ARNm de Moderna y Pfizer. Estos cambios han sido aprobados oficialmente por los CDC. Ahora se permite una dosis adicional de vacuna bivalente para: ➡️ Personas de al menos 65 años con más Read more…
What is this drug Ozempic I keep hearing about?
General Health
Sara Gorman, PhD, MPH
A: Ozempic is a drug used to treat diabetes and has lately been touted as a helpful option to stimulate weight loss. Ozempic (semaglutide) was approved in 2017 for the treatment of diabetes. Sometime in 2022, the drug’s manufacturer, Novo Nordisk, announced that the drug was in short supply in part due to “incredible” demand. Read more…
La FDA, por sus siglas en inglĂ©s, modificĂł la autorizaciĂłn de uso de emergencia en los Estados Unidos de las vacunas de ARNm de Moderna y Pfizer. Estos cambios han sido aprobados oficialmente por los CDC. Ahora se permite una dosis adicional de vacuna bivalente para: ➡️ Personas de al menos 65 años con más Read more…
What is this drug Ozempic I keep hearing about?
General HealthSara Gorman, PhD, MPH
A: Ozempic is a drug used to treat diabetes and has lately been touted as a helpful option to stimulate weight loss. Ozempic (semaglutide) was approved in 2017 for the treatment of diabetes. Sometime in 2022, the drug’s manufacturer, Novo Nordisk, announced that the drug was in short supply in part due to “incredible” demand. Read more…
A: Ozempic is a drug used to treat diabetes and has lately been touted as a helpful option to stimulate weight loss. Ozempic (semaglutide) was approved in 2017 for the treatment of diabetes. Sometime in 2022, the drug’s manufacturer, Novo Nordisk, announced that the drug was in short supply in part due to “incredible” demand. Read more…
